Pes Anserine Bursitis / Tendinopathy

The VerdictMODERATE CONVICTION

Inner-knee pain that scans call "normal" is usually an irritated tendon attachment just below the joint.

Press one fingertip on the inside of your shin, about two inches below the knee joint. If that exact spot reproduces your pain — and the joint line itself doesn't — that points to pes anserine pain. This is how it is actually diagnosed: by where it hurts, not by a scan.

What's really happening: three thigh muscles share one anchor point on the inside of your shin, and that anchor point, not the knee joint, is what's irritated.
What most people get wrong: chasing the sore spot with rubs, scans and injections while ignoring the real load on it — usually body weight, a worn knee joint, or a training spike.
Start here: take the strain off it (ease back stairs and running volume) and deal with the thing actually loading it.

Three of your thigh muscles share a single anchor point on the inside of your shin, like three ropes tied to one stake. When the load through that stake stays too high for too long — extra body weight, a worn knee joint pulling things off balance, a sudden jump in running — the anchor point gets irritated and sore. It settles when you take the strain off the stake, not when you poke at the sore patch.

What Works

Honest framing first: there is no strong-evidence (multiple-trial) treatment for this condition, and no condition-specific clinical guideline. The grades below are faithful to a thin evidence base. The pathway that is consistent across every review is the same: diagnose it clinically, manage the load, and treat what's driving it before reaching for an injection.

Cinematic anatomical view of the inner knee and proximal tibia

Tier 1 — Best Available MODERATE

Load management + treat the upstream driver. Ease the activities that flare it, lose weight if you're carrying extra, control blood sugar if you're diabetic, and manage any co-existing knee osteoarthritis on its own pathway. This is the foundation everything else sits on — an injection on top of an unaddressed driver just buys time.

Ultrasound-guided corticosteroid injection — for symptoms that persist despite a real conservative trial. Ultrasound guidance reaches the target far more reliably than a blind injection. Expect relief within a week, but expect it to fade if the driver isn't dealt with. Cap at 3 or fewer per year.

Exercise Prescription

Keep pain at 2 out of 10 or less during the exercise and in the 24 hours after. If it flares past that, drop back a level.

Hamstring stretch — 3 holds of 30 seconds each leg, daily. Sit on the edge of a chair, one leg straight with the heel down, lean forward gently from the hips.

Inner-thigh squeeze — 3 sets of 10, daily. Cushion between the knees, squeeze gently and hold 5-10 seconds.

Mini wall sit — 3 holds of 20-30 seconds, most days. Back against a wall, slide down into a shallow knee bend, hold, stand back up.

Controlled step-down — 3 sets of 8 each leg, every other day once comfortable. Stand on a low step, lower the other foot slowly under control.

See Tier 2 & Tier 3 options

Tier 2 — Limited evidence MODERATE / LOW

Short-course NSAIDs (oral or topical) for symptom control during the conservative trial.
Oxygen-ozone or 20% dextrose prolotherapy injection — one trial suggested longer-lasting relief than corticosteroid at 8 weeks, but it had no placebo arm.

Tier 3 — Weak / emerging LOW

Leukocyte-rich PRP injection — one trial showed within-patient improvement but no placebo comparison.
Kinesiotaping — one small trial was positive but a published critique flagged methodology weaknesses.
Mesotherapy (subcutaneous diclofenac) — one trial, non-standardised technique.
Arthroscopic debridement — reserved for genuinely refractory cases after a full conservative and injection course.

What Doesn't Work

Diagnosing off the scan. Calling incidental bursal fluid "bursitis", or ruling the condition out because the scan is clean. The diagnosis is clinical.
Blind (unguided) injection. It misses the target in the majority of cases.
Treating the sore spot in isolation. Ignoring the body weight, diabetes, or knee osteoarthritis driving it, so it recurs after every injection.
Chaining corticosteroid injections. If a guided injection didn't give a durable result, the answer is to rethink the driver, not inject again.
Transarterial embolization. Experimental, case-report-level only. Not a recommended pathway.

Red Flags

Most inner-knee pain is not dangerous. But stop self-managing and get seen if any of these apply:

Sudden swelling or pain in the calf or lower leg. A ruptured pes anserine bursa can mimic a deep vein clot (DVT) exactly — the two cannot be told apart without a proper assessment. This is a same-day check, not a "flare".
The area is hot, red, you feel feverish or unwell — or the pain started for no clear reason in someone with poorly-controlled diabetes. This can be an infection. Do not inject it.
A lump that is growing or feels fixed in place. Needs imaging to rule out a tumour.
New foot drop, or numbness or weakness that is getting worse. Possible nerve involvement.

Refer to: A&E or urgent same-day care for a suspected DVT or infected joint. GP or orthopaedics for an enlarging lump. Do not inject any knee with red-flag features until they are resolved.

Return to Training

Concrete, measurable criteria — not "when it feels ready". All should be true before returning to full load:

Focal point tenderness over the insertion resolved or minimal
Full pain-free knee range of motion under load
Can perform loaded knee work (step-downs, squats) at your previous level with pain 2/10 or less
No symptom flare beyond 2/10 in the 24 hours after a full training session
Symptom-stable for 2 consecutive weeks at full training load

This is how the condition is actually diagnosed: by where it hurts, not by a scan.

Takes less than a minute. No equipment needed.

Conviction MODERATE

The condition is clinically real and recognisable, and the pathway — clinical diagnosis, conservative-first, ultrasound-guided injection for failures — is consistent across every review. But it earns only a MODERATE rating: every treatment rung rests on small, mostly placebo-free trials in older, knee-osteoarthritis-comorbid patients, and the single most-recommended treatment, exercise, has no published trial at all.

What would change this: A properly powered trial of clinically-diagnosed pes anserine pain comparing 12 weeks of supervised exercise vs ultrasound-guided injection vs the combination, with a sham arm and 6- and 12-month pain and function outcomes.

What would change my mind: "diagnose by point tenderness, not imaging"

A formal diagnostic-accuracy study that puts a real sensitivity and specificity figure on the clinical exam — currently the field asserts the clinical diagnosis without one. If imaging were shown to reliably separate symptomatic from asymptomatic tissue, the "imaging can't confirm it" claim would weaken.

What would change my mind: "conservative care before injection"

A properly powered head-to-head trial showing ultrasound-guided injection clearly beats structured conservative care on 6- and 12-month outcomes — no such trial exists yet. The current sequencing is logical and consensus-backed but untested.

Go Deeper

Tired of guessing whether your knee pain is the joint, the tendon, or something that needs a scan? The Verdict breaks down one injury or health question every week — evidence-scored, jargon-free, free.

Join The Verdict — free weekly protocols

The Full Picture — Anatomy, Diagnosis & Evidence

What's Actually Going On

Cinematic anatomical view of the pes anserinus tendon insertion on the inner shin

The pes anserinus — Latin for "goose's foot", named for its shape — is the shared insertion of three tendons (sartorius, gracilis, and semitendinosus) onto the inner surface of the shin bone, about 5 to 7 cm below the knee joint line. A small fluid-filled bursa cushions the area.

Pain here was historically called "bursitis", implying the bursa is inflamed. The current literature is moving toward "pes anserine pain syndrome" because the tissue actually driving the pain may be the bursa, the tendons themselves, or the surrounding fascia — or a combination. The anatomy is also highly variable: one cadaveric study identified six different morphological types, which is part of why palpation landmarks and blind injections are unreliable.

It is almost always an associated condition, not an isolated one. The usual drivers are medial-compartment knee osteoarthritis, extra body weight, type 2 diabetes, and mechanical overload (a running-volume spike, poor lower-limb alignment, direct trauma).

How to Identify It

Cinematic anatomical view of the medial knee assessment region

The diagnosis is clinical. The hallmark is focal, fingertip-localised tenderness over the insertion point, with pain on stairs (especially going down), on rising from a low chair, and sometimes at night when the knees touch.

Focal palpation of the pes anserine insertion Sn/Sp: not established — reproduces the patient's familiar pain at the insertion, distinct from joint-line tenderness.
Resisted knee flexion / internal rotation Sn/Sp: not established — loads the conjoined tendons; supportive when positive but not diagnostic.

There is no validated special test with published accuracy figures for this condition. Imaging confirms anatomy, not the diagnosis — bursal fluid is common in pain-free knees and often absent in painful ones. Use imaging to exclude other problems or to guide an injection, not to confirm pes anserine pain.

The Debate

"Bursitis" vs "pain syndrome"

Older view: the condition is inflammation of the anserine bursa, confirmed by imaging.

Recent evidence: symptomatic patients frequently show no bursal distension, and bursal fluid is common incidentally in pain-free knees. The driver may be bursal, tendinopathic, or fasciial. Higher-resolution ultrasound in osteoarthritis cohorts exposed this mismatch (Aicale 2024; Abicalaf 2021).

Is a steroid injection a durable fix?

Older view: a corticosteroid injection resolves it.

Recent evidence: corticosteroid gives good relief at 1 week, but it is not durable — at 8 weeks, oxygen-ozone and dextrose prolotherapy outperformed it in a multicentre trial of 72 patients (Babaei-Ghazani 2024). And ultrasound-guided injection reaches the target far more often than a blind one: in one trial, the injectate reached the bursa in all subjects vs 4 of 22 with the blind technique (Lee 2019; Finnoff 2010).

No condition-specific clinical practice guideline exists. Management is operationalised inside knee osteoarthritis pathways and clinical-consensus documents.

Honest Limitations

The front-line treatment has no trial

Reviews recommend hamstring stretching plus closed-chain quadriceps strengthening as first-line. There is no published exercise-prescription trial for this condition. The recommendation is expert consensus, not trial evidence.

Every injection trial lacks a placebo arm

"Both groups improved" is the recurring result — but in a partly self-limiting condition, that cannot separate the injection from natural recovery.

The studied patients aren't the assumed patients

The evidence base is mostly older, overweight, frequently diabetic, often female, with co-existing knee osteoarthritis. The "young runner with an overuse injury" is the least-studied subgroup — applying this data to them is extrapolation.

The Nuance

Cinematic anatomical view of the knee in low dramatic light

This is a condition you manage conservatively. The evidence base is thin across the board, but it is consistent on one point: there is no surgical shortcut, and there is no durable injection shortcut either.

Surgery — arthroscopic debridement — is rare and reserved for genuinely refractory, disabling cases after a documented full course of conservative care and an appropriate ultrasound-guided injection, with the driver already addressed. Precise conservative-care success rates are not available because no good prospective cohort exists, but the condition is described as self-limiting in most cases, with a recovery window that ranges widely from around 10 days to many months. The work is load management and treating the body weight, the blood sugar, and the knee osteoarthritis underneath it. Most people settle with that — even if "settle" can take months.

Sources

Aicale R et al., 2024, Eur J Musculoskelet Dis — comprehensive review; most symptomatic patients show no morphological imaging change, bursal distension is not synonymous with clinical bursitis, field moving toward a "syndrome" framing.
Babaei-Ghazani A et al., 2024, Am J Phys Med Rehabil (PMID 37752656) — randomized multicentre trial, N=72; corticosteroid and oxygen-ozone favoured at 1 week, oxygen-ozone and prolotherapy favoured at 8 weeks.
Lee JH et al., 2019, J Clin Ultrasound (PMID 30378129) — randomized trial, N=47; ultrasound-guided injection reached the target bursa in all subjects vs 4 of 22 blind, with better pain scores at 1 and 4 weeks.
Finnoff JT et al., 2010, PM&R (PMID 20598959) — single-blind randomized cadaveric study, 24 specimens; ultrasound-guided injection accuracy 92%.
Abicalaf CARP et al., 2021, Sci Rep (PMID 34400659) — prospective observational study, N=100; pes anserine bursitis among the most frequent ultrasound findings in symptomatic knee osteoarthritis.
Yagi S et al., 2019, J Med Invest (PMID 31064945) — case report; pes anserine bursa rupture as a differential for acute unilateral lower-leg swelling, a DVT mimic.